Quantum Genesis AI Corp.

Quantumzyme Corp. is a biotransformation company focused on clean and green chemistry, specifically developing engineered enzymes for active pharmaceutical ingredient ("API") production. The company conducts research to enhance enzyme activity, selectivity, and specificity using novel quantum mechanics, molecular modeling, and engineering approaches. Quantumzyme aims to simplify complex chemistry and reduce production steps for chemical companies. The company has engineered its first product, an enzyme for use in pharmaceutical API production of Ibuprofen, specifically targeting pharmaceutical companies that produce generic drugs. Quantumzyme is currently identifying third-party manufacturers and distributors for large-scale manufacturing and distribution of this product. As of the date of this report, the company has not filed for patent protection for this product and does not anticipate doing so in the near future, as the associated costs currently outweigh the anticipated benefits.